Advertisement

Benzylisoquinolinium Compounds in the Critically Ill Patient

  • Jennifer M. Hunter
Conference paper

Abstract

Two main groups of neuromuscular blocking drugs are available for use in the Intensive Therapy Unit (ITU): the aminosteroids and the benzylisoquinolinium compounds. These drugs are occasionally used in such patients in addition to analgesics and sedatives, to manage patients undergoing artificial ventilation. They are given not only to effect tracheal intubation, gastroscopy, bronchoscopy, etc., but also in the continued management of the critically ill.

Keywords

Multiple Organ Failure Intensive Care Patient Status Asthmaticus Plasma Cholinesterase Critical Illness Polyneuropathy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Van Miert M.M., Hunter J.M. (1994). Neuromuscular blocKing agents in critically ill patients. Current Opinion in Anaesthesiology. 7, 394–9.CrossRefGoogle Scholar
  2. 2.
    Zochodne D.W., Bolton F., Wells G.A., Gilbert J.J., Hahn A.F., Brown J.D., Sibbald W.A. (1987). Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain. 110, 819–42.PubMedCrossRefGoogle Scholar
  3. 3.
    Horton W.A., Ferguson N.V. (1988). Hyperkalaemia and cardiac arrest after the use of suxamethonium in intensive care. Anaesthesia. 43, 890–1.PubMedCrossRefGoogle Scholar
  4. 4.
    Segredo V., Caldwell J.E., Matthay M.A., Sharma M.L., Gruenke L.D., Miller R.D. (1992). Persistent paralysis in critically ill patients after long-term administration of vecuronium. New England Journal of Medicine. 327, 524–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Vandenbrom R.H.G., Wierda J.M.K.H. (1988). Pancuronium bromide in the intensive care unit: a case of overdose. Anesthesiology. 69, 996–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Hansen-Flaschen J., Cowen J., Raps E.P. (1993). Neuromuscular blockade in the intensive care unit: more than we bargained for. American Review of Respiratory Diseases. 147, 234–6.CrossRefGoogle Scholar
  7. 7.
    Meyer K.C., Prielipp R.C., Grossman J.E., Coursin D.B. (1994). Prolonged weakness after infusion of atracurium in two intensive care unit patients. Anesthesia and Analgesia. 78, 772–4.PubMedCrossRefGoogle Scholar
  8. 8.
    Griffiths R.B., Hunter J.M., Jones R.S. (1986). Atracurium infusions in patients with renal failure on an ITU. Anaesthesia. 41, 375–81.PubMedCrossRefGoogle Scholar
  9. 9.
    Parker C.J.R., Jones J.E., Hunter J.M. (1988). Disposition of infusions of atracurium and its metabolite, laudanosine, in patients in renal and respiratory failure in an ITU. British Journal of Anaesthesia. 61, 531–40.PubMedCrossRefGoogle Scholar
  10. 10.
    Parker C.J.R., Hunter J.M. (1989). Pharmacokinetics of atracurium and laudanosine in patients with hepatic cirrhosis. British Journal of Anaesthesia. 62, 177–83.PubMedCrossRefGoogle Scholar
  11. 11.
    Shi W-Z, Fahey M.R., Fisher D.M., Miller R.D. (1989). Modification of central nervous system effects of laudanosine by inhalational anaesthetics. British Journal of Anaesthesia. 63, 598–600.PubMedCrossRefGoogle Scholar
  12. 12.
    Fahey M.R., Rupp S.M., Canfell P.C., Fisher D.M., Miller R.D., Sharma M., Castagnoli K., Hennis P.J. (1985). Effect of renal failure on laudanosine excretion in man. British Journal of Anaesthesia. 57, 1049–51.PubMedCrossRefGoogle Scholar
  13. 13.
    Yate P.M., Flynn P.J., Arnold R.W., Weatherley B.C., Simmonds R.J., Dopson J. (1987). Clinical experience and plasma laudanosine concentrations during atracurium infusion in the intensive therapy unit. British Journal of Anaesthesia. 59, 211–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Gwinnutt C.L., Eddleston J.M., Edwards D., Pollard B.J. (1990). Concentrations of atracurium and laudanosine in cerebrospinal fluid and plasma in three intensive care patients. British Journal of Anaesthesia. 65, 829–32.PubMedCrossRefGoogle Scholar
  15. 15.
    Tsui D., Graham G.G., Torda T.A. (1987). The pharmacokinetics of atracurium isomers in vitro and in humans. Anesthesiology. 67, 722–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Stone A.J., Pollard B.J., Harper N.J.N. (1994). Infusion requirements of patients receiving 51W89 in the intensive care unit. British Journal of Anaesthesia. 72, 486P–7P.Google Scholar
  17. 17.
    Coursin D., Murray M., Scuderi P., Prough D., Abou-Donia M., Miller D. (1993). An evaluation of doxacurium and pancuronium in a multi-center, randomised, double-blind study in the critically ill. Critical Care Medicine. 21, S263.CrossRefGoogle Scholar

Copyright information

© Springer Japan 1995

Authors and Affiliations

  • Jennifer M. Hunter
    • 1
  1. 1.Department of AnesthesiaRoyal Liverpool University HospitalLiverpoolUK

Personalised recommendations